Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
iHeartMedia
IHRT
$576M
| $7.15M | ﹤0.01% |
856,693
+378,671
| +79% | +$2.95M |
|
2127
OrthoPediatrics
KIDS
$559M
| $7.15M | ﹤0.01% |
163,338
+15,604
| +11% | +$702K |
|
|
AXDX
2128
DELISTED
Accelerate Diagnostics
AXDX
| $7.13M | ﹤0.01% |
47,001
+2,433
| +5% | +$240K |
|
2129
Core Laboratories
CLB
$503M
| $7.12M | ﹤0.01% |
350,634
-10,053
| -3% | -$180K |
|
2130
Helix Energy Solutions
HLX
$1.37B
| $7.11M | ﹤0.01% |
2,050,371
+91,466
| +5% | +$247K |
|
|
TRTX
2131
TPG RE Finance Trust
TRTX
$607M
| $7.11M | ﹤0.01% |
826,621
+84,423
| +11% | +$613K |
|
|
RDUS
2132
DELISTED
Radius Recycling
RDUS
| $7.09M | ﹤0.01% |
401,745
-19,743
| -5% | -$305K |
|
2133
MBIA
MBI
$269M
| $7.08M | ﹤0.01% |
976,425
-156,117
| -14% | -$1.13M |
|
2134
Viking Therapeutics
VKTX
$3.88B
| $7.07M | ﹤0.01% |
981,029
+14,115
| +1% | +$93.7K |
|
2135
QCR Holdings
QCRH
$1.72B
| $7.07M | ﹤0.01% |
226,797
+4,998
| +2% | +$144K |
|
|
SP
2136
DELISTED
SP Plus Corporation
SP
| $7.05M | ﹤0.01% |
340,600
-4,267
| -1% | -$88K |
|
2137
LeMaitre Vascular
LMAT
$1.85B
| $7.04M | ﹤0.01% |
266,830
-5,355
| -2% | -$140K |
|
|
JOBS
2138
DELISTED
51job Inc
JOBS
| $7.04M | ﹤0.01% |
98,549
-760
| -0.8% | -$49.9K |
|
2139
CEL-SCI Corp
CVM
$26M
| $7.03M | ﹤0.01% |
15,708
+128
| +0.8% | +$52.5K |
|
2140
Origin Bancorp
OBK
$1.7B
| $7M | ﹤0.01% |
318,358
+42,609
| +15% | +$874K |
|
2141
Imperial Oil
IMO
$60.6B
| $7M | ﹤0.01% |
435,602
+14,732
| +4% | +$221K |
|
2142
Construction Partners
ROAD
$6.01B
| $7M | ﹤0.01% |
393,896
+4,223
| +1% | +$72K |
|
|
POLY
2143
DELISTED
Plantronics, Inc.
POLY
| $6.99M | ﹤0.01% |
475,951
+19,077
| +4% | +$249K |
|
|
TPC
2144
Tutor Perini Cor
TPC
$4.47B
| $6.97M | ﹤0.01% |
572,700
+11,673
| +2% | +$104K |
|
2145
Harmonic Inc
HLIT
$1.31B
| $6.95M | ﹤0.01% |
1,463,537
+124,332
| +9% | +$695K |
|
|
FBMS
2146
DELISTED
The First Bancshares, Inc.
FBMS
| $6.94M | ﹤0.01% |
308,622
+45,875
| +17% | +$932K |
|
|
ACH
2147
Accendra Health
ACH
$228M
| $6.94M | ﹤0.01% |
910,800
+26,435
| +3% | +$193K |
|
2148
Quanterix
QTRX
$176M
| $6.94M | ﹤0.01% |
253,236
+38,015
| +18% | +$961K |
|
|
UMH
2149
UMH Properties
UMH
$1.3B
| $6.93M | ﹤0.01% |
535,935
+11,616
| +2% | +$140K |
|
|
EIDX
2150
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $6.93M | ﹤0.01% |
145,348
+3,805
| +3% | +$177K |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.